
- Volume 0 0
Molecule Triggers Fat in Liver
Research has proven that saturated fats and trans fattyacids cause high levels of cholesterol and triglycerides. Bothare risk factors in cardiovascular disease and some types ofcancer. A new study identified a molecule in the liver thatexplains how eating fatty foods increases the risk of heartdisease and cancer.
The researchers reported that the harmful effects of saturatedand trans fats are activated by PGC-1beta, a biochemicalswitch located in the liver cells. The investigatorsexplained that, when PGC-1beta is set in motion by harmfulfats, it alters liver metabolism and causes an upsurge of theliver's production of very low-density lipoprotein (VLDL). Inturn, the VLDL produces low-density lipoprotein. Furthermore,it manufactures higher levels of triglycerides.
Articles in this issue
almost 21 years ago
Heart Patients Get More Appropriate Rx Treatment from Cardiologistsalmost 21 years ago
Surgeon General Report Blasts Rx Drug Importing Practicesalmost 21 years ago
Mevacor a Pharmacist-Only OTC? No Way, Advisory Group Tells FDAalmost 21 years ago
Expo Focuses on Caregiver Needsalmost 21 years ago
Early-Month Rx Fatalities Linked to Overworked Pharmacistsalmost 21 years ago
Feds Report Rx Expenditures Rose More Slowly in 2004almost 21 years ago
Rx.com Offers Alternative to PBM Mail Orderalmost 21 years ago
Americans Rate US Health Care as Pooralmost 21 years ago
Pharmacy Security Combo Pack Now Availablealmost 21 years ago
IOM Advocates Tougher Supplement StandardsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

















































































































































































































